Category: Sin categoría

Aurora again rejects Curaleaf’s hostile bid, open until 4 December. The numbers, the arguments and what it means for European medical cannabis.

Medical cannabis reaches Spanish hospital pharmacies a year after Royal Decree 903/2025. What it means for growers, labs and pharma distributors.

France awaits a Conseil d’État ruling on its reimbursement decree to complete its medical cannabis framework. Which products qualify and when the market opens.

Portugal clears Tilray to test flower batches at its EU-GMP site in Cantanhede. What it means for costs, lead times and European medical cannabis supply.

Bedrocan, the only licensed medical cannabis grower in the Netherlands, is bankrupt. The BMC will import in 2027: what it means for EU-GMP producers.

Italy’s Constitutional Court moves its review of the Article 18 hemp flower ban to 9 February 2027. What changes, and what doesn’t, for hemp businesses.

Dunbar Pharma brings the UK’s first plant-derived dronabinol oral spray. What the EU-GMP API plus Specials model means for cannabis businesses.

Germany’s coalition amends the mandatory six-month trial with licensed cannabis medicines. Flower stays out of reimbursement. What it means for the industry.

The OMC stops exporting, Bedrocan enters suspension of payments and Denmark fears a supply gap in 2027. What it means for Europe’s cannabis trade.

Swiss SCRIPT trial sells cannabis in 9 pharmacies: use does not rise, smoking falls and vaping and tinctures grow. Key data for the cannabis industry.